Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-27

Clinical Trial Update: Effect of Age on the Median Effective Concentration(EC50) for Motor Block With Spinal Plain Bupivacaine

View source ↗

Summary

A clinical trial studying how age affects the median effective concentration of spinal plain bupivacaine for motor block has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: China Three Gorges University, Yichang, China | Conditions: Mononeuropathy of the Median Nerve, Mild | Status: WITHDRAWN